eagle-i Harvard UniversityHarvard University
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Technology Development Grant

eagle-i ID


Resource Type

  1. Support service


  1. Resource Description
    "The TDG is awarded annually and can provide up to $150,000 to advance later stage technologies, where the concept has been proven. This award is intended to add value to the technology to increase the probability of licensing to an established company or start-up. The application process begins by submitting a Letter of Intent (.pdf). Successful applications are invited to submit a Full Proposal (.doc), as well as a brief presentation to an external advisory board. The grant can be used for: * Prototype development * Human clinical data * Pre-clinical package * Drug delivery * Large animal studies * Other advanced pre-commercial research Eligibility * The application must be based on intellectual property (IP) developed at the Children's Hospital with the rights assigned to Children's Hospital. The principal investigator must be a Children's Hospital employee. * For the application to be considered for evaluation, a complete invention disclosure must be on file with TIDO. * At least one patent application should be filed with USPTO on the technology prior to submission of the Letter of Intent (LOI). The patent strategy and commercialization path for the technology must be well defined."
  2. Additional Name
  3. Service Provided by
    Technology and Innovation Development Office (BCH)
  4. Website(s)
  5. ERO_0001053
Provenance Metadata About This Resource Record

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016